STOCK TITAN
  1. Home
  2. Sec-filings
  3. CAH
  4. [Form 4] CARDINAL HEALTH INC Insider Trading Activity

Cardinal Health (NYSE: CAH) CEO sells 124K shares around $233–$238

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

CARDINAL HEALTH INC (CAH) reported that Chief Executive Officer Jason M. Hollar sold an aggregate of 124,529 Common Shares in 10 open-market or private transactions on August 18–19, 2026. The reported weighted average sale prices ranged from approximately $232.75 to $238.07 per share, with each line item reflecting multiple trades within the stated price ranges.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Hollar Jason M.
Role Chief Executive Officer
Sold 124,529 shs ($29.38M)
Type Security Shares Price Value
Sale Common Shares F5 6,206 $233.22 $1.45M
Sale Common Shares F6 3,457 $234.29 $810K
Sale Common Shares F7 5,704 $235.34 $1.34M
Sale Common Shares F8 6,731 $236.46 $1.59M
Sale Common Shares F9 16,187 $237.23 $3.84M
Sale Common Shares F10 6,244 $237.88 $1.49M
Sale Common Shares F1 21,407 $234.56 $5.02M
Sale Common Shares F2 29,915 $235.51 $7.05M
Sale Common Shares F3 16,208 $236.54 $3.83M
Sale Common Shares F4 12,470 $237.25 $2.96M
Holdings After Transaction: Common Shares — 190,603 shares (Direct)
Footnotes (10)
  1. F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1-10 to this Form 4.
  2. F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.07 to $236.065, inclusive.
  3. F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.07 to $237.05, inclusive.
  4. F4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.08 to $237.67, inclusive.
  5. F5. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.75 to $233.74, inclusive.
  6. F6. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.75 to $234.735, inclusive.
  7. F7. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.77 to $235.59, inclusive.
  8. F8. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.77 to $236.765, inclusive.
  9. F9. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.77 to $237.735, inclusive.
  10. F10. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.065, inclusive.
Total shares sold 124,529 shares Aggregate non-derivative Common Shares sold by Jason M. Hollar on August 18–19, 2026
Transactions count 10 transactions Number of reported sale transactions coded “S” for Common Shares
Lowest price range low $232.75 per share Lower bound of price range for sales referenced in footnote F5
Highest price range high $238.065 per share Upper bound of price range for sales referenced in footnote F10
Largest single reported block 29,915 shares Common Shares sold on August 18, 2026 at a weighted average price of $235.51
Next largest reported block 21,407 shares Common Shares sold on August 18, 2026 at a weighted average price of $234.56
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"transaction_code_description: Sale in open market or private transaction"
non-derivative financial
"transaction_type: non-derivative"

FAQ

What insider transaction did CAH CEO Jason Hollar report on this Form 4?
Jason M. Hollar reported sales of 124,529 Cardinal Health (CAH) Common Shares across 10 transactions on August 18–19, 2026. All transactions were reported as open-market or private sales of directly held shares.

Over what dates did Jason Hollar sell Cardinal Health (CAH) shares?
Jason Hollar sold Cardinal Health (CAH) Common Shares on August 18 and 19, 2026. The Form 4 groups these sales into 10 separate non-derivative transactions, each with its own weighted average sale price and price range footnote.

How many Cardinal Health (CAH) shares did Jason Hollar sell in total?
Jason Hollar sold a total of 124,529 CAH Common Shares, according to the transaction summary. These sales are spread across 10 reportable transactions, all coded as “S” for sale of non-derivative common shares held directly.

What price range did Jason Hollar receive for his CAH share sales?
The weighted average prices reported ranged from about $232.75 to $238.07 per share. Footnotes explain each reported price is a weighted average for multiple trades executed within narrower ranges on the respective transaction dates.

Were Jason Hollar’s CAH share sales under a Rule 10b5-1 trading plan?
The Form 4’s Rule 10b5-1 checkbox is not marked as affirmatively adopted, and the footnotes do not reference a trading plan. The filing therefore does not indicate these specific sales were executed pursuant to a Rule 10b5-1 plan.

What type of security did Jason Hollar sell in Cardinal Health (CAH)?
All reported transactions involve non-derivative Common Shares of Cardinal Health, Inc.. Each entry shows directly held common shares coded “S” for sale, with no options or other derivative securities reported in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hollar Jason M.
(Last)(First)(Middle)
7000 CARDINAL PLACE
(Street)
DUBLIN OHIO 43017
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares08/18/2026S21,407D$234.56(1)293,725D
Common Shares08/18/2026S29,915D$235.51(2)263,810D
Common Shares08/18/2026S16,208D$236.54(3)247,602D
Common Shares08/18/2026S12,470D$237.25(4)235,132D
Common Shares08/19/2026S6,206D$233.22(5)228,926D
Common Shares08/19/2026S3,457D$234.29(6)225,469D
Common Shares08/19/2026S5,704D$235.34(7)219,765D
Common Shares08/19/2026S6,731D$236.46(8)213,034D
Common Shares08/19/2026S16,187D$237.23(9)196,847D
Common Shares08/19/2026S6,244D$237.88(10)190,603D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1-10 to this Form 4.
2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.07 to $236.065, inclusive.
3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.07 to $237.05, inclusive.
4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.08 to $237.67, inclusive.
5. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.75 to $233.74, inclusive.
6. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.75 to $234.735, inclusive.
7. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.77 to $235.59, inclusive.
8. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.77 to $236.765, inclusive.
9. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.77 to $237.735, inclusive.
10. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.065, inclusive.
Remarks:
/s/ Amanda S. Pashi, Attorney-in-fact08/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR